# About Deep Dive Peptides — An Independent Cognitive Research Desk

> About Deep Dive Peptides: an independent literature digest on Semax and Selank. How it is compiled, what it covers, and what it is not — not a seller, not a clinic, not medical advice.

An independent, citation-anchored digest of research on neuroactive peptides. Not a vendor. Not a clinic. Not medical advice.

## What Deep Dive Peptides is

Deep Dive Peptides is an independent editorial reading desk covering the published research on two peptides studied for **cognition, focus, mood, anxiety, and sleep**: Semax and Selank, with Semax as the lead compound. The site exists to make a scattered, geographically concentrated, and frequently misrepresented literature readable — to tell a curious person, in plain language with citations, what each compound was actually studied for, in which species, and how far that evidence honestly reaches.

The organizing idea is the distinction between two complementary approaches to cognitive neuroactive peptides: Semax as a neurotrophic and neuroprotective compound (BDNF, NGF, cerebral ischemia), and Selank as a non-benzodiazepine anxiolytic compound (GABA modulation, enkephalin stabilization, stress response). Reading them together gives a richer picture of what research peptides in this space actually do and do not do, than reading either one alone.

Each compound has its own page with mechanism, findings, community-reported signals, and cited safety cautions; a comparison page lines them up side by side; and a single aggregated references list collects every source cited across the desk.

## How it is compiled

Three principles govern what appears on this site.

*First, everything is anchored to the peer-reviewed literature.* Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, with DOIs and PubMed links — collected on the [references page](/references). Where a finding comes from a review article rather than a primary study, the review is cited as such, and we distinguish its level of evidence from primary data.

*Second, the evidence is reported at its actual strength.* Doses are described the way the study described them — for example, *a single 50 micrograms per kilogram intranasal dose in male Wistar rats* — never scaled to humans or offered as a recommendation. Where evidence is preclinical, single-lab, from a geographically narrow institutional base, or published in Russian with English abstracts only, the text says so plainly. That candor about limits is the point of the desk.

*Third, community-reported effects are included but clearly labeled.* For compounds like Semax and Selank that are used outside any clinical framework, the nootropics-forum and peptide-community anecdotal record is a real part of the picture — but it is labeled throughout as "anecdotal, not clinical evidence" and kept separate from what peer-reviewed studies actually established. Honest coverage of these compounds means covering both.

## What it is not

Deep Dive Peptides is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose any condition, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person.

The peptides discussed here are research compounds that are not approved medicines in the US or EU. Readers with genuine health concerns should consult a licensed clinician operating in their own jurisdiction, with access to regulated, evidence-based options. The value this site offers is a careful, accurate reading of the available literature — nothing more, and nothing it pretends to be.

---

Peer-reviewed research, carefully read — a literature digest, not a clinic or a vendor, and never a dose.